Please use this identifier to cite or link to this item: http://hdl.handle.net/1942/19860
Title: Long-term efficacy and safety of prolonged-release fampridine treatment in patients with multiple sclerosis: design of the multicentre, randomised, double-blind, placebo-controlled ENHANCE study
Authors: Ziemssen, T.
Hobart, J.
FEYS, Peter 
Linnebank, M.
Goodman, A.
McNeill, M.
Zhong, J.
Mehta, L.
Issue Date: 2015
Publisher: WILEY-BLACKWELL
Source: EUROPEAN JOURNAL OF NEUROLOGY, 22 (S1), p. 621-621
Notes: [Ziemssen, T.] Univ Clin Dresden, Dresden, Germany. [Hobart, J.] Univ Plymouth, Peninsula Sch Med, Plymouth Hosp NHS Trust, Plymouth PL4 8AA, Devon, England. [Hobart, J.] Univ Plymouth, Peninsula Sch Dent, Plymouth Hosp NHS Trust, Plymouth PL4 8AA, Devon, England. [Feys, P.] Univ Hasselt, Diepenbeek, Belgium. [Linnebank, M.] Univ Zurich Hosp, CH-8091 Zurich, Switzerland. [Goodman, A.] Univ Rochester, Med Ctr, Sch Med & Dent, Rochester, NY 14642 USA. [McNeill, M.] Biogen Idec Inc, Maidenhead, Berks, England. [Zhong, J.; Mehta, L.] Biogen Idec Inc, Cambridge, MA USA.
Document URI: http://hdl.handle.net/1942/19860
ISSN: 1351-5101
e-ISSN: 1468-1331
ISI #: 000364239000254
Rights: © 2015 European Journal of Neurology
Category: M
Type: Journal Contribution
Appears in Collections:Research publications

Files in This Item:
File Description SizeFormat 
selection (34).pdf
  Restricted Access
194.07 kBAdobe PDFView/Open    Request a copy
Show full item record

Page view(s)

36
checked on Jul 28, 2023

Download(s)

12
checked on Jul 28, 2023

Google ScholarTM

Check


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.